Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  Hsp90 inhibitor AT13387
Find trials that include:  Any drugs shown
Results 1-3 of 3 for your search:
Start Over
Hsp90 Inhibitor AT13387, Dabrafenib, and Trametinib in Treating Patients with Recurrent Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 14-186, NCI-2014-00615, 9557, NCT02097225
Hsp90 Inhibitor AT13387 in Treating Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck Receiving Radiation Therapy and Cisplatin
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 to 70
Trial IDs: PJC-XXX, NCI-2015-00256, 9874, NCT02381535
HSP90 Inhibitor AT13387 and Paclitaxel in Treating Patients with Advanced Triple Negative Breast Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 9876, NCI-2015-00866, NCT02474173
Start Over